The broad, long term objective of this research program is to define the mechanism of action of thyrotropin-releasing hormone (TRH) so as to better understand the mechanism of cell regulation by all extracellular signal molecules, such as hormones, neurotransmitters and growth factors and of some pathologic processes that disorder cell regulation. Specifically, the molecular biology of the TRH receptor from anterior pituitary cells will be studied. A complementary DNA (cDNA) for the TRH receptor has very nearly been cloned. The cloning strategy involved expression of a functional TRH receptor from a mouse pituitary thyroid-stimulating hormone-producing (TtT) tumor in Xenopus laevis oocytes. We first propose to sequence the cDNA and then use it and the deduced amino acid sequence of the receptor protein in studies to define the tissue distribution of the TRH receptor, the structure-function relations of the TRH receptor, in particular the molecular details of its relations of the TRH receptor, in particular the molecular details of its interaction with TRH and its coupling to a guanine nucleotide binding regulatory (G) protein, and the mechanism of modulation of TRH receptor number, which is a proven mechanism for regulation of TRH action. Studies will be performed using GH3 rat pituitary glands and rat tissues. A sequencing stategy using the dideoxynucleotide method has been devised. In situ hybridization will be performed with radiolabeled cDNA probes. Selective mutations of the cDNA will be made and then used to transform GH-Y cells, a subclone of GH3 without TRH receptors or detectable receptor mRNA activity, to define the functional domains of the TRH receptor. And, the mechanism of regulation of TRH receptor number will be studied by measuring the levels and synthesis and degradation rates of the receptor protein and mRNA, with complementary measurements of mRNA activity made in Xenopus oocytes to determine whether there are changes in translational efficiency. Phosphorylation of the TRH receptor will be studied as a possible mechanism of its regulation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043036-03
Application #
3244303
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1990-07-06
Project End
1995-06-30
Budget Start
1992-07-01
Budget End
1993-06-30
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Meena, Chhuttan L; Thakur, Avinash; Nandekar, Prajwal P et al. (2015) Synthesis of CNS active thyrotropin-releasing hormone (TRH)-like peptides: Biological evaluation and effect on cognitive impairment induced by cerebral ischemia in mice. Bioorg Med Chem 23:5641-53
Meena, Chhuttan L; Ingole, Shubdha; Rajpoot, Satyendra et al. (2015) Discovery of a low affinity thyrotropin-releasing hormone (TRH)-like peptide that exhibits potent inhibition of scopolamine-induced memory impairment in mice. RSC Adv 5:56872-56884
Maillet, Emeline L; Cui, Meng; Jiang, Peihua et al. (2015) Characterization of the Binding Site of Aspartame in the Human Sweet Taste Receptor. Chem Senses 40:577-86
Cui, Meng; Jiang, Peihua; Maillet, Emeline et al. (2006) The heterodimeric sweet taste receptor has multiple potential ligand binding sites. Curr Pharm Des 12:4591-600
Kentsis, Alex; Mezei, Mihaly; Osman, Roman (2005) Origin of the sequence-dependent polyproline II structure in unfolded peptides. Proteins 61:769-76
Kentsis, Alex; Mezei, Mihaly; Gindin, Tatyana et al. (2004) Unfolded state of polyalanine is a segmented polyproline II helix. Proteins 55:493-501
Kentsis, Alex; Mezei, Mihaly; Osman, Roman (2003) MC-PHS: a Monte Carlo implementation of the primary hydration shell for protein folding and design. Biophys J 84:805-15
Simpson, Jill C; Ho, Chris; Shands, E F Berkley et al. (2002) Conformationally restricted TRH analogues: constraining the pyroglutamate region. Bioorg Med Chem 10:291-302
Gershengorn, M C; Osman, R (2001) Minireview: Insights into G protein-coupled receptor function using molecular models. Endocrinology 142:2-10
Harder, S; Lu, X; Wang, W et al. (2001) Regulator of G protein signaling 4 suppresses basal and thyrotropin releasing-hormone (TRH)-stimulated signaling by two mouse TRH receptors, TRH-R(1) and TRH-R(2). Endocrinology 142:1188-94

Showing the most recent 10 out of 48 publications